EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Attending an integrated nephrology and diabetology outpatient service can improve diabetic kidney disease treatment: a single-center experience

S Wolde Sellasie, C Pecchioli, K Cersosimo, I Nardone, S Zaccaria, A Centi, P Di Perna, P Tatangelo, P Sperti, G Schifano, L Giurato, A Bellia und 2 weitere

Acta Diabetologica · 2025

DOI: 10.1007/s00592-024-02423-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Diabetologica, 2025. Verfasst von S Wolde Sellasie und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Diabetes, Department of Biomedicine and Prevention, CTO Andrea Alesini Hospital, University of Rome Tor Vergata, 00133,…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Nephrology, Ambulatory Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Roma Tor Vergata.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucose-lowering medications with established reno-protective effects are still underused in Italy. We explored whether attending an integrated nephrology and diabetology (NPD) outpatient service can improve clinical outcomes and adherence to treatment guidelines for diabetic kidney disease (DKD).

Methods

We retrospectively included 110 DKD patients (aged 71.1 ± 10.1 years; 74.5% males) having attended the NPD outpatient service of CTO Hospital (Rome) between June and November 2023. Age- and gender-matched control group included DKD patients attending regular Diabetology outpatient service. Drugs prescriptions, clinical and biochemical parameters related to routine evaluation of DKD were collected at first and 6-months control visit.

Results

This DKD population was made of 28.2% of patients with urine albumin-creatinine ratio (UACR) > 30 mg/gr, 33.6% with glomerular filtration rate (GFR) < 60 ml/min, 38.2% with both abnormalities. Proportion of patients prescribed with most recent anti-diabetic medications significantly increased after attending the NPD service (for SGLT-2 inhibitors, 54.5 vs. 25.5%, p < 0.01; for GLP1-R agonists, 28.3 vs. 21.8%, p = 0.01), as well as for statins ( p < 0.01) and calcium channel-blockers ( p = 0.01). During the same observation period we registered significant reduction in LDL cholesterol ( p = 0.01) and UACR levels ( p = 0.007), with a trend toward improvement in HbA1c and eGFR. Conversely, no significant differences in drugs prescriptions were reported in the control group, except for SGLT-2 inhibitors.

Conclusions

Enhanced real-time interaction and collaborative decision-making in an outpatient setting that integrates both diabetology and nephrology expertise can lead to better clinical outcomes and greater adherence to DKD management guidelines, ultimately providing a more comprehensive strategy for cardio-renal risk reduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesNephrologyAmbulatory CareHumansMaleFemaleAgedRetrospective StudiesMiddle AgedHypoglycemic AgentsItalyGlomerular Filtration RateAged, 80 and overSodium-Glucose Transporter 2 InhibitorsOutpatientsDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

Chronic kidney diseaseDiabetic kidney diseaseDiabetic nephropathySGLT-2 inhibitors

Substanzen

Hypoglycemic AgentsSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Division of Endocrinology and Diabetes, Department of Biomedicine and Prevention, CTO Andrea Alesini Hospital, University of Rome Tor Vergata, 00133, Rome, Italy.
  • PhD School of Applied Medical-Surgical Sciences, University of Rome Tor Vergata, 00133, Rome, Italy.
  • Unit of Nephrology, Sant' Eugenio Hospital, 00144, Rome, Italy.
  • School of Specialization in Food Sciences, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy.
  • Department of Systems Medicine, University of Rome "Tor Vergata", Via Montpellier 1, 00133, Rome, Italy. bellia@med.uniroma2.it.

Förderung

  • Università degli Studi di Roma Tor Vergata

Zitieren

APA

Sellasie, S. W., Pecchioli, C., Cersosimo, K., Nardone, I., Zaccaria, S., Centi, A., Di Perna, P., Tatangelo, P., Sperti, P., Schifano, G., Giurato, L., Bellia, A., Palumbo, R., & Uccioli, L. (2025). Attending an integrated nephrology and diabetology outpatient service can improve diabetic kidney disease treatment: a single-center experience. Acta Diabetologica. https://doi.org/10.1007/s00592-024-02423-w

Vancouver

Sellasie SW, Pecchioli C, Cersosimo K, Nardone I, Zaccaria S, Centi A, et al. Attending an integrated nephrology and diabetology outpatient service can improve diabetic kidney disease treatment: a single-center experience. Acta Diabetologica. 2025. doi:10.1007/s00592-024-02423-w

BibTeX
@article{Sellasie2025,
  author = {Sellasie, S Wolde and Pecchioli, C and Cersosimo, K and Nardone, I and Zaccaria, S and Centi, A and Di Perna, P and Tatangelo, P and Sperti, P and Schifano, G and Giurato, L and Bellia, A and Palumbo, R and Uccioli, L},
  title = {Attending an integrated nephrology and diabetology outpatient service can improve diabetic kidney disease treatment: a single-center experience},
  journal = {Acta Diabetologica},
  year = {2025},
  doi = {10.1007/s00592-024-02423-w}
}
Kostenlos starten →